z-logo
Premium
Issues in xenotransplantation absence of hyperacute rejection in newborn pig‐to‐baboon cardiac xenografts
Author(s) -
Ascher Nancy L.
Publication year - 1995
Publication title -
liver transplantation and surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1074-3022
DOI - 10.1002/lt.500010508
Subject(s) - xenotransplantation , baboon , transplantation , antibody , complement system , immunology , medicine , pathology , heart transplantation , biology
The shortage of organs for transplantation is especially severe for the critically ill newborn infant, for whom donors of the appropriate size are particularly scarce. One way to overcome this problem is to use animals in lieu of human as organ donors. The major limitation to using animals for this purpose is the susceptibility of animal organs to hyperacute rejection, a violent rejection reaction thought to be mediated by antidonor antibody and complement. To evaluate the potential application of xenotransplantation to newborns, we tested neonatal humans and neonatal baboons, and found that neither populatioh expressed significant levels of xenoreactive antipig antibodies. We transplanted heterotopically hearts from newborn pigs into unmanipulated newborn baboons (n = 4). There was no evidence of hyperacute rejection in any of the grafts; the animals were killed with functioning grafts at 15, 81, and 82 hour. This outcome contrasts with that of newborn pig‐to‐mature baboon and mature pig‐to‐mature baboon cardiac xenografts, which were rejected within one hour of transplantation. The histology of pig graft biopsies from the new born recipients was normal. Immunohistochemistry revealed only traces of IgM, C3, C4 and the membrane attack complex along graft endothelium. Fibrin deposition along endothelial surfaces was observed early after transplantation and became more extensive with time; in the absence of endothelial bound antibody or complement, this change may represent preservation injury. This study suggests that due to low levels of natural antibody, the newborn infant may permit prolonged xenograft survival.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here